Stealth BioTherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MITO and buy or sell other stocks, ETFs, and their options commission-free!About MITO
Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA.
CEOIrene P. McCarthy
CEOIrene P. McCarthy
Employees—
Employees—
HeadquartersGeorge Town, George Town
HeadquartersGeorge Town, George Town
Founded2006
Founded2006
Employees—
Employees—
MITO Key Statistics
Market cap20.98M
Market cap20.98M
Price-Earnings ratio-0.35
Price-Earnings ratio-0.35
Dividend yield—
Dividend yield—
Average volume400.33K
Average volume400.33K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.00
52 Week high$1.00
52 Week low$0.1621
52 Week low$0.1621
Stock Snapshot
Stealth BioTherapeutics(MITO) stock is priced at $0.32, giving the company a market capitalization of 20.98M. It carries a P/E multiple of -0.35.
Stealth BioTherapeutics(MITO) stock opened on 2025-12-17 at —. The price climbed to — and dipped to —.
Stealth BioTherapeutics(MITO) shares are trading with a volume of 0, against a daily average of 400.33K.
In the last year, Stealth BioTherapeutics(MITO) shares hit a 52-week high of $1.00 and a 52-week low of $0.16.
In the last year, Stealth BioTherapeutics(MITO) shares hit a 52-week high of $1.00 and a 52-week low of $0.16.